a double blind randomized study of Clopidogrel 75 mg/d versus placebo on a background of ASA 75-100 mg/d, in peripheral disease (PAD) patient receiving a unilateral below knee by-pass graft

Mise à jour : Il y a 4 ans
Référence : EUCTR2004-000822-58